Medtronic Plc Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#8A0CCF;color: white;font-size:4em;padding-top: 15px;;'>ME</div>
MDT -- USA Stock  

Fiscal Quarter End: January 31, 2020  

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding Medtronic plc is 'Strong Hold'. Macroaxis provides Medtronic Plc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MDT positions. The advice algorithm takes into account all of Medtronic plc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from MDT buy-and-hold prospective. Additionally see Medtronic Plc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell Medtronic PlcBuy Medtronic Plc
Strong Hold


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon Medtronic plc has a risk adjusted performance of 0.0871, jensen alpha of 0.1275, total risk alpha of (0.07), sortino ratio of 0.0232 and treynor ratio of 1.49
Macroaxis provides buy or sell recommendations on Medtronic plc to complement and cross-verify current analyst consensus on Medtronic Plc. Our advice engine determines the firm potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Medtronic plc is not overpriced, please verify all Medtronic plc fundamentals including its Cash per Share, Beta and the relationship between Revenue and Cash Flow from Operations . Given that Medtronic plc has Price to Earning of 33.99 , we recommend you check Medtronic Plc market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Medtronic Plc Trading Alerts and Improvement Suggestions

Medtronic Plc current analysts recommendations

Target Median Price124.00
Target Mean Price125.27
Recommendation Mean2.00
Target High Price136.00
Number Of Analyst Opinions22
Target Low Price108.00

Medtronic Plc Returns Distribution Density

Mean Return0.15Value At Risk1.39
Potential Upside1.30Standard Deviation0.86
 Return Density 

Medtronic Plc Greeks

Alpha over DOW
Beta against DOW=0.09
Overall volatility
Information ratio =0.0244

Medtronic Plc Volatility Alert

Medtronic plc has low volatility with Treynor Ratio of 1.49, Maximum Drawdown of 4.34 and kurtosis of 0.54. However, we advice all investors to further analyze Medtronic plc to make certain all market information is desiminated and is consistent with the current expectations about Medtronic Plc upside potential.
 Better Than Average     
 Worse Than Average Compare Medtronic Plc to competition

Medtronic Plc Fundamental Vs Peers

FundamentalsMedtronic PlcPeer Average
Return On Equity0.0018 (0.31) 
Return On Asset0.001 (0.14) 
Profit Margin0.0017 (1.27) 
Operating Margin30.61 (5.51) 
Current Valuation165.85 B16.62 B
Shares Outstanding1.34 B571.82 M
Shares Owned by Insiders0.07 10.09 
Shares Owned by Institutions84.78 39.21 
Number of Shares Shorted9.88 M4.71 M
Price to Earning33.99 28.72 
Price to Book2.95 9.51 
Price to Sales4.85 11.42 
Revenue30.67 B9.43 B
Gross Profit21.49 B27.38 B
EBITDA9.44 B3.9 B
Net Income4.42 B570.98 M
Cash and Equivalents10.69 B2.7 B
Cash per Share7.97 5.01 
Total Debt27.24 B5.32 B
Debt to Equity53.90 48.70 
Current Ratio2.67 2.16 
Book Value Per Share22.24 1.93 K
Cash Flow from Operations3.65 B971.22 M
Short Ratio2.63 4.00 
Earnings Per Share3.26 3.12 
Price to Earnings To Growth2.79 4.89 
Number of Employees90 K18.84 K
Market Capitalization148.71 B19.03 B
Total Asset99.64 B29.47 B
Retained Earnings21 B9.33 B
Working Capital16.43 B1.48 B
Current Asset23.6 B9.34 B
   Exercise or conversion by Collins Arthur D Jr of 52652 shares of Medtronic Plc subject to Rule 16b-3 [view details]